Creating engineered cell strains represents a critical method for studying gene function and pathology pathways. This report outlines the core ideas behind generating engineered cell lines, covering methods like CRISPR-Cas9, RNA interference (RNAi), and homologous recombination. Furthermore, we explore significant considerations, including off-targ